No abstract available
Publication types
-
Clinical Trial
-
Randomized Controlled Trial
MeSH terms
-
Antineoplastic Combined Chemotherapy Protocols / adverse effects
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
Biomarkers, Tumor / blood
-
Bleomycin / administration & dosage
-
Bleomycin / adverse effects
-
Chorionic Gonadotropin / blood
-
Chorionic Gonadotropin, beta Subunit, Human
-
Cisplatin / administration & dosage
-
Cisplatin / adverse effects
-
Cyclophosphamide / administration & dosage
-
Cyclophosphamide / adverse effects
-
Doxorubicin / administration & dosage
-
Doxorubicin / adverse effects
-
Drug Evaluation
-
Female
-
Humans
-
Indiana / epidemiology
-
Male
-
Neoplasms, Germ Cell and Embryonal / blood
-
Neoplasms, Germ Cell and Embryonal / drug therapy*
-
Neoplasms, Germ Cell and Embryonal / mortality
-
Neoplasms, Germ Cell and Embryonal / pathology
-
Peptide Fragments / blood
-
Randomized Controlled Trials as Topic
-
Survival Rate
-
Texas / epidemiology
-
Vinblastine / administration & dosage
-
Vinblastine / adverse effects
Substances
-
Biomarkers, Tumor
-
Chorionic Gonadotropin
-
Chorionic Gonadotropin, beta Subunit, Human
-
Peptide Fragments
-
Bleomycin
-
Vinblastine
-
Doxorubicin
-
Cyclophosphamide
-
Cisplatin
Supplementary concepts
-
CISCA(II)-VB(IV) protocol